logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Valparaiso, Indiana

Verified
+12194648302
Source: Site record.
https://velocityclinicaltrials.com/locations/velocity-clinical-research-valparaiso

Basic Information

Site Overview

Source: Google.

Velocity's Valparaiso research site was founded in 2004 by Dr. Robert Buynak as Buynak Clinical Research, an independent dedicated research center, and acquired by Velocity in 2020. Our Valparaiso site conducts studies in a number of internal medicine indications, with particular expertise in diabetes and other metabolic disorders, such as obesity, COPD and emphysema trials.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Trial-derived.
22Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
4Active Trials
Source: Trial-derived.
17Completed Trials
Source: Trial-derived.
19Unique Conditions
Source: Trial-derived.
14Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Diabetes Mellitus, Type 2 (5)Source: Trial-derived. Obesity (4)Source: Trial-derived. Chronic Kidney Disease (3)Source: Trial-derived. Pneumococcal Vaccines (2)Source: Trial-derived. Cardiovascular Risk (1)Source: Trial-derived. Covid19 (1)Source: Trial-derived. Dyslipidemia (1)Source: Trial-derived. Inflammation (1)

Sponsors

Source: Trial-derived. Novo Nordisk A/S (9)Source: Trial-derived. Janssen Vaccines & Prevention B.V. (2)Source: Trial-derived. Vaxcyte, Inc. (2)Source: Trial-derived. Brigham and Women's Hospital (1)Source: Trial-derived. Department of Health and Human Services (1)Source: Trial-derived. Golo (1)Source: Trial-derived. Janssen Research & Development, LLC (1)Source: Trial-derived. Kowa Research Institute, Inc. (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Echocardiography
Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. PBMC isolation & cryopreservation
Source: AI-inferred. Sequencing / genomics

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. ELISpot assay
Source: AI-inferred. Electronic clinical outcome assessment (eCOA/e-Diary) platform
Source: AI-inferred. Electronic participant diary (eDiary) system
Source: AI-inferred. Electronic patient-reported outcome (eDiary) system
Source: AI-inferred. Hemagglutination inhibition (HAI) antibody assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Microneutralization assay